Home - Boston Life Sciences Times

LATEST ARTICLES

Venture Capital

Startup Shutdowns Shift to Later Stages as First AI Reckoning Emerges, Report Finds

Life Sciences Times - December 23, 20250

Biotech

Agenus Reports Durable Responses in Refractory Ovarian Cancer With Botensilimab and Balstilimab

Life Sciences Times - December 23, 20250

Pharma

Zai Lab Announces China Approval of COBENFY as First-in-Class Schizophrenia Treatment

Life Sciences Times - December 23, 20250

Real Estate

BioMed Realty Highlights Sustainability Progress and GRESB Recognition in 2024 Report

Life Sciences Times - December 23, 20250

Venture Capital

Fulgent Genetics to Acquire Bako Diagnostics and StrataDx in $55.5 Million Deal

Life Sciences Times - December 23, 20250

Biotech

Zambon Biotech Doses First Patient in Phase 3b ADIP Study of IPX203 for Parkinson’s Disease

Life Sciences Times - December 22, 20250

Pharma

Savara Resubmits FDA Application for MOLBREEVI in Autoimmune Pulmonary Alveolar Proteinosis

Life Sciences Times - December 22, 20250

Pharma

KalVista Wins Japanese Approval for EKTERLY, First Oral On-Demand Treatment for Hereditary Angioedema

Life Sciences Times - December 22, 20250

Public Health

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

Life Sciences Times - December 22, 20250

Pharma

ENHERTU Granted FDA Breakthrough Therapy Designation as Post-Neoadjuvant Treatment for HER2-Positive Early Breast Cancer

Life Sciences Times - December 22, 20250

1...565758...831 Page 57 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

POPULAR CATEGORY

ABOUT US

FOLLOW US